Narrative review / 2021
Reviews find no clear evidence supporting generalized iodine supplementation in mild-to-moderate deficiency settings for pregnant women or infants.
This review evaluated recent data on iodine deficiency, its health impacts, and the need for supplementation in at-risk groups. According to the 2019 Iodine Global Network Annual Report, 23 countries were classified as having insufficient iodine intake in 2019, reduced from 113 in 1993. Two Cochrane reviews in 2017 and 2019 found no evidence that iodine supplementation in women before, during, or after pregnancy improved infant and child cognitive development in mild-to-moderate deficiency areas. Additionally, a 2019 Cochrane review found no evidence that iodine supplementation improved mortality or morbidity, including cognitive impairment, in preterm infants.
- Study type
- Narrative review
- Who was studied
- Pregnant and lactating women, infants (preterm and term), and young children
- What was measured
- Cognitive development, child neurodevelopment, morbidity, and mortality
THE PAPER
Iodine supplementation: is there a need?
Ley D, Turck D. Curr Opin Clin Nutr Metab Care, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.